DHRS9 Human (1->4)-beta-D-glucan multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DHRS9 mRNA CTD PMID:36331819 DHRS9 Human 1-naphthyl isothiocyanate increases expression ISO Dhrs9 (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of DHRS9 mRNA CTD PMID:30723492 DHRS9 Human 17alpha-ethynylestradiol increases expression ISO Dhrs9 (Rattus norvegicus) 6480464 Ethinyl Estradiol results in increased expression of DHRS9 mRNA CTD PMID:15834898 DHRS9 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of DHRS9 mRNA and Estradiol promotes the reaction [DHRS9 protein binds to TMEM121B promoter] CTD PMID:20404318 DHRS9 Human 17beta-estradiol increases expression ISO Dhrs9 (Mus musculus) 6480464 Estradiol results in increased expression of DHRS9 mRNA CTD PMID:26879975 DHRS9 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:23146750 DHRS9 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Dhrs9 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of DHRS9 mRNA CTD PMID:22298810 DHRS9 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Dhrs9 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of DHRS9 mRNA CTD PMID:34747641 DHRS9 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Dhrs9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of DHRS9 mRNA CTD PMID:28213091 DHRS9 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Dhrs9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of DHRS9 mRNA CTD PMID:28922406 DHRS9 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DHRS9 mRNA CTD PMID:25975270 DHRS9 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of DHRS9 mRNA CTD PMID:23152189 DHRS9 Human 3,3',4,4',5-pentachlorobiphenyl affects expression EXP 6480464 3 more ... CTD PMID:21703328 DHRS9 Human 3,3',5,5'-tetrabromobisphenol A increases expression ISO Dhrs9 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of DHRS9 mRNA CTD PMID:25172293 DHRS9 Human 3,7-dihydropurine-6-thione increases expression ISO Dhrs9 (Rattus norvegicus) 6480464 Mercaptopurine results in increased expression of DHRS9 mRNA CTD PMID:23358152 DHRS9 Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of DHRS9 mRNA CTD PMID:19194470 DHRS9 Human 9-cis-retinoic acid increases expression EXP 6480464 Alitretinoin results in increased expression of DHRS9 mRNA CTD PMID:11304534 DHRS9 Human acetamide increases expression ISO Dhrs9 (Rattus norvegicus) 6480464 acetamide results in increased expression of DHRS9 mRNA CTD PMID:31881176 DHRS9 Human afimoxifene decreases expression ISO Dhrs9 (Mus musculus) 6480464 afimoxifene results in decreased expression of DHRS9 mRNA CTD PMID:26879975 DHRS9 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of DHRS9 mRNA CTD PMID:22100608 and PMID:32234424 DHRS9 Human aflatoxin M1 decreases expression EXP 6480464 Aflatoxin M1 results in decreased expression of DHRS9 mRNA CTD PMID:30928695 DHRS9 Human aldehydo-D-glucose multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DHRS9 mRNA CTD PMID:37567420 DHRS9 Human all-trans-retinoic acid multiple interactions ISO Dhrs9 (Rattus norvegicus) 6480464 [DHRS9 protein affects the expression of ALDH1A1 mRNA] which affects the chemical synthesis of Tretinoin and [DHRS9 protein affects the expression of ALDH1A1 protein] which affects the chemical synthesis of Tretinoin CTD PMID:21138835 DHRS9 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of DHRS9 mRNA CTD PMID:11304534 more ... DHRS9 Human all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with arsenic trioxide] results in increased expression of DHRS9 mRNA CTD PMID:15894607 DHRS9 Human all-trans-retinoic acid increases chemical synthesis ISO Dhrs9 (Rattus norvegicus) 6480464 DHRS9 protein results in increased chemical synthesis of Tretinoin CTD PMID:21138835 DHRS9 Human all-trans-retinol increases metabolic processing EXP 6480464 DHRS9 protein results in increased metabolism of Vitamin A CTD PMID:11304534 DHRS9 Human alpha-Zearalanol multiple interactions ISO Dhrs9 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DHRS9 mRNA CTD PMID:35163327 DHRS9 Human ammonium chloride affects expression ISO Dhrs9 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of DHRS9 mRNA CTD PMID:16483693 DHRS9 Human antimonite multiple interactions EXP 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DHRS9 mRNA CTD PMID:32076005 DHRS9 Human arotinoid acid multiple interactions EXP 6480464 [4-(2-(5 more ... CTD PMID:34480604 DHRS9 Human arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DHRS9 mRNA CTD PMID:32525701 DHRS9 Human arsane multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DHRS9 mRNA CTD PMID:32045263 DHRS9 Human arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DHRS9 mRNA CTD PMID:32525701 DHRS9 Human arsenic atom multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DHRS9 mRNA CTD PMID:32045263 DHRS9 Human arsenite(3-) multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of DHRS9 mRNA CTD PMID:32076005 DHRS9 Human arsenous acid multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of DHRS9 mRNA CTD PMID:15894607 DHRS9 Human avobenzone decreases expression EXP 6480464 avobenzone results in decreased expression of DHRS9 mRNA CTD PMID:31016361 DHRS9 Human benzene increases expression EXP 6480464 Benzene results in increased expression of DHRS9 mRNA CTD PMID:19162166 DHRS9 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of DHRS9 promoter CTD PMID:27901495 DHRS9 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of DHRS9 mRNA CTD PMID:32234424 DHRS9 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of DHRS9 mRNA CTD PMID:30453624 DHRS9 Human beta-naphthoflavone decreases expression EXP 6480464 beta-Naphthoflavone results in decreased expression of DHRS9 mRNA CTD PMID:32858204 DHRS9 Human bis(2-ethylhexyl) phthalate decreases expression ISO Dhrs9 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of DHRS9 mRNA CTD PMID:28085963 DHRS9 Human bisphenol A decreases expression ISO Dhrs9 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of DHRS9 mRNA CTD PMID:25181051 DHRS9 Human bisphenol A increases expression ISO Dhrs9 (Mus musculus) 6480464 bisphenol A results in increased expression of DHRS9 mRNA CTD PMID:32156529 DHRS9 Human bisphenol A increases expression ISO Dhrs9 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of DHRS9 mRNA CTD PMID:30816183 DHRS9 Human butanal increases expression EXP 6480464 butyraldehyde results in increased expression of DHRS9 mRNA CTD PMID:25014914 and PMID:26079696 DHRS9 Human butane-2,3-dione increases expression EXP 6480464 Diacetyl results in increased expression of DHRS9 mRNA CTD PMID:30710127 DHRS9 Human carbon nanotube increases expression ISO Dhrs9 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of DHRS9 mRNA CTD PMID:25554681 DHRS9 Human CHIR 99021 multiple interactions EXP 6480464 [4-(2-(5 more ... CTD PMID:34480604 DHRS9 Human chlorpyrifos increases expression ISO Dhrs9 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of DHRS9 mRNA CTD PMID:32715474 DHRS9 Human choline multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of DHRS9 mRNA CTD PMID:29127188 DHRS9 Human copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of DHRS9 mRNA CTD PMID:20971185 DHRS9 Human copper atom decreases expression ISO Dhrs9 (Rattus norvegicus) 6480464 Copper results in decreased expression of DHRS9 mRNA CTD PMID:30556269 DHRS9 Human copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of DHRS9 mRNA CTD PMID:20971185 DHRS9 Human copper(0) decreases expression ISO Dhrs9 (Rattus norvegicus) 6480464 Copper results in decreased expression of DHRS9 mRNA CTD PMID:30556269 DHRS9 Human cortisol multiple interactions EXP 6480464 [4-(2-(5 more ... CTD PMID:34480604 DHRS9 Human crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of DHRS9 mRNA CTD PMID:25351596 DHRS9 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of DHRS9 mRNA CTD PMID:27989131 DHRS9 Human cypermethrin decreases expression ISO Dhrs9 (Mus musculus) 6480464 cypermethrin results in decreased expression of DHRS9 mRNA CTD PMID:31659573 DHRS9 Human cypermethrin multiple interactions ISO Dhrs9 (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of DHRS9 mRNA] CTD PMID:31659573 DHRS9 Human D-glucose multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DHRS9 mRNA CTD PMID:37567420 DHRS9 Human DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of DHRS9 mRNA CTD PMID:38568856 DHRS9 Human dextran sulfate increases expression ISO Dhrs9 (Mus musculus) 6480464 Dextran Sulfate results in increased expression of DHRS9 mRNA CTD PMID:23894361 DHRS9 Human diarsenic trioxide multiple interactions EXP 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of DHRS9 mRNA CTD PMID:15894607 DHRS9 Human dimethylarsinic acid multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DHRS9 mRNA CTD PMID:34876320 DHRS9 Human dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of DHRS9 mRNA CTD PMID:26516004 DHRS9 Human dioxygen multiple interactions ISO Dhrs9 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of DHRS9 mRNA CTD PMID:33729688 DHRS9 Human dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions EXP 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DHRS9 mRNA CTD PMID:32076005 DHRS9 Human disodium selenite multiple interactions ISO Dhrs9 (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of DHRS9 mRNA] CTD PMID:31659573 DHRS9 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of DHRS9 mRNA CTD PMID:29803840 DHRS9 Human epoxiconazole affects expression ISO Dhrs9 (Mus musculus) 6480464 epoxiconazole affects the expression of DHRS9 mRNA CTD PMID:35436446 DHRS9 Human fluoranthene multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of DHRS9 mRNA CTD PMID:28329830 DHRS9 Human fluoranthene increases expression ISO Dhrs9 (Mus musculus) 6480464 fluoranthene results in increased expression of DHRS9 mRNA CTD PMID:28329830 DHRS9 Human folic acid multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of DHRS9 mRNA CTD PMID:29127188 DHRS9 Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of DHRS9 mRNA CTD PMID:27664576 DHRS9 Human fructose multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DHRS9 mRNA CTD PMID:37567420 DHRS9 Human glucose multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DHRS9 mRNA CTD PMID:37567420 DHRS9 Human Heliotrine increases expression EXP 6480464 heliotrine results in increased expression of DHRS9 mRNA CTD PMID:26100227 DHRS9 Human hexanal increases expression EXP 6480464 n-hexanal results in increased expression of DHRS9 mRNA CTD PMID:25014914 DHRS9 Human isotretinoin multiple interactions EXP 6480464 [vorinostat co-treated with Isotretinoin] results in increased expression of DHRS9 mRNA CTD PMID:18769122 DHRS9 Human isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of DHRS9 mRNA CTD PMID:20436886 DHRS9 Human L-ascorbic acid multiple interactions EXP 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DHRS9 mRNA CTD PMID:34480604 DHRS9 Human L-ascorbic acid 2-phosphate multiple interactions EXP 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DHRS9 mRNA CTD PMID:34480604 DHRS9 Human L-methionine multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of DHRS9 mRNA CTD PMID:29127188 DHRS9 Human lipopolysaccharide multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DHRS9 mRNA CTD PMID:35811015 DHRS9 Human mercaptopurine increases expression ISO Dhrs9 (Rattus norvegicus) 6480464 Mercaptopurine results in increased expression of DHRS9 mRNA CTD PMID:23358152 DHRS9 Human methylarsonic acid multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DHRS9 mRNA CTD PMID:34876320 DHRS9 Human methylisothiazolinone increases expression EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of DHRS9 mRNA CTD PMID:31629900 DHRS9 Human NAD zwitterion multiple interactions EXP 6480464 NAD binds to and results in increased activity of DHRS9 protein CTD PMID:25526675 DHRS9 Human NAD(+) multiple interactions EXP 6480464 NAD binds to and results in increased activity of DHRS9 protein CTD PMID:25526675 DHRS9 Human O-methyleugenol increases expression EXP 6480464 methyleugenol results in increased expression of DHRS9 mRNA CTD PMID:32234424 DHRS9 Human octanal increases expression EXP 6480464 caprylic aldehyde results in increased expression of DHRS9 mRNA CTD PMID:25014914 DHRS9 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of DHRS9 mRNA CTD PMID:26690555 DHRS9 Human paracetamol increases expression ISO Dhrs9 (Mus musculus) 6480464 Acetaminophen results in increased expression of DHRS9 mRNA CTD PMID:29246445 DHRS9 Human paracetamol multiple interactions ISO Dhrs9 (Mus musculus) 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of DHRS9 mRNA] CTD PMID:29246445 DHRS9 Human paracetamol multiple interactions EXP 6480464 [Dietary Carbohydrates co-treated with Acetaminophen] results in increased expression of DHRS9 mRNA CTD PMID:17093179 DHRS9 Human paraquat increases expression ISO Dhrs9 (Rattus norvegicus) 6480464 Paraquat results in increased expression of DHRS9 mRNA CTD PMID:32680482 DHRS9 Human pentanal increases expression EXP 6480464 pentanal results in increased expression of DHRS9 mRNA CTD PMID:25014914 and PMID:26079696 DHRS9 Human pentane-2,3-dione increases expression EXP 6480464 2 and 3-pentanedione results in increased expression of DHRS9 mRNA CTD PMID:30710127 DHRS9 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DHRS9 mRNA CTD PMID:36331819 DHRS9 Human perfluorooctanoic acid multiple interactions ISO Dhrs9 (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DHRS9 mRNA CTD PMID:35163327 DHRS9 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of DHRS9 mRNA CTD PMID:37738295 DHRS9 Human phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of DHRS9 mRNA CTD PMID:19084549 DHRS9 Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of DHRS9 mRNA CTD PMID:19159669 DHRS9 Human pirinixic acid increases expression ISO Dhrs9 (Mus musculus) 6480464 pirinixic acid results in increased expression of DHRS9 mRNA CTD PMID:23811191 DHRS9 Human propanal increases expression EXP 6480464 propionaldehyde results in increased expression of DHRS9 mRNA CTD PMID:25014914 and PMID:26079696 DHRS9 Human purine-6-thiol increases expression ISO Dhrs9 (Rattus norvegicus) 6480464 Mercaptopurine results in increased expression of DHRS9 mRNA CTD PMID:23358152 DHRS9 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DHRS9 mRNA CTD PMID:35811015 DHRS9 Human SB 431542 multiple interactions EXP 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DHRS9 mRNA CTD PMID:34480604 DHRS9 Human senecionine increases expression EXP 6480464 senecionine results in increased expression of DHRS9 mRNA CTD PMID:26100227 DHRS9 Human Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of DHRS9 mRNA CTD PMID:26100227 DHRS9 Human serpentine asbestos increases expression EXP 6480464 Asbestos and Serpentine results in increased expression of DHRS9 mRNA CTD PMID:21148743 DHRS9 Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of DHRS9 mRNA and Silicon Dioxide results in increased expression of DHRS9 mRNA CTD PMID:25351596 and PMID:25895662 DHRS9 Human sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DHRS9 mRNA CTD PMID:32525701 DHRS9 Human sodium arsenate multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DHRS9 mRNA CTD PMID:34876320 DHRS9 Human sodium arsenite multiple interactions EXP 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of DHRS9 mRNA CTD PMID:32076005 DHRS9 Human sodium arsenite multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of DHRS9 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DHRS9 mRNA CTD PMID:32045263 and PMID:34876320 DHRS9 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of DHRS9 mRNA CTD PMID:34032870 DHRS9 Human streptozocin multiple interactions ISO Dhrs9 (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of DHRS9 mRNA CTD PMID:29127188 DHRS9 Human Theaflavin 3,3'-digallate affects expression EXP 6480464 theaflavin-3 and 3'-digallate affects the expression of DHRS9 mRNA CTD PMID:34925699 DHRS9 Human thioacetamide increases expression ISO Dhrs9 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of DHRS9 mRNA CTD PMID:23411599 DHRS9 Human toluene affects expression ISO Dhrs9 (Rattus norvegicus) 6480464 Toluene affects the expression of DHRS9 mRNA CTD PMID:18653662 DHRS9 Human tributylstannane decreases expression ISO Dhrs9 (Mus musculus) 6480464 tributyltin results in decreased expression of DHRS9 mRNA CTD PMID:31939706 DHRS9 Human triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of DHRS9 mRNA CTD PMID:30510588 DHRS9 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of DHRS9 mRNA CTD PMID:37042841 DHRS9 Human troglitazone increases expression EXP 6480464 troglitazone results in increased expression of DHRS9 mRNA CTD PMID:19140230 and PMID:25572481 DHRS9 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of DHRS9 mRNA CTD PMID:29154799 DHRS9 Human vorinostat multiple interactions EXP 6480464 [vorinostat co-treated with Isotretinoin] results in increased expression of DHRS9 mRNA CTD PMID:18769122 DHRS9 Human XAV939 multiple interactions EXP 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DHRS9 mRNA and [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DHRS9 mRNA CTD PMID:34480604
